• Avellino Labs
    Cataract/Anterior Segment, Cornea/External Disease

    Avellino Labs has developed a genetic screening test to predict keratoconus risk in Asian patients.

    After sequencing DNA from more than 200 keratoconus patients worldwide, Avellino identified 4 variations within 3 genes that confer a significantly greater risk for keratoconus. These variants were found in 9% to 21% of keratoconus patients in Korea. Due to the high prevalence within an Asian population, Avellino plans to launch the test in Korea, Japan and China in the first quarter of 2017.

    "At Avellino Labs we are excited to be able to offer the first genetic predictor of relative risk of keratoconus in Asian eyes, which often hits in the prime of life and progressively impairs vision over time, said John Marshall, PhD, member of the Avellino medical advisory board and professor of ophthalmology at Moorfields Eye Hospital. “Most importantly, the Avellino DNA Test represents a sea change detecting keratoconus early in order to inform surgeons performing laser vision correction and to improve keratoconus patient care.”

    The company plans to expand the diagnostic platform, and aims to provide a comprehensive assay for definitive keratoconus risk factors for patients across the world.